EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

A Retrospective Comparative Study of Sodium Ferulate Combined With Methylcobalamin for Oxaliplatin-Induced Peripheral Neuropathy in Patients With Colorectal Cancer

Baojun Min, Li Wan, Hongyong He, Jie Chen, Zhonglu Jian, Rong Chen

British Journal of Hospital Medicine · 22.06.2026 · 87 (6)

DOI: 10.31083/bjhm55138 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 22.06.2026. Verfasst von Baojun Min und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Qianxi People's Hospital, 551599 Bijie, Guizhou, China. Hauptthemen laut MEDLINE: Vitamin B 12, Peripheral Nervous System Diseases, Oxaliplatin, Colorectal Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Provincial Science and Technology Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Background: Oxaliplatin-induced peripheral neuropathy (OIPN) is a common dose-limiting toxic effect of oxaliplatin-based chemotherapy for colorectal cancer (CRC), severely affecting patients’ quality of life and treatment adherence. Currently, effective therapeutic options for OIPN are limited. This study aimed to investigate the clinical efficacy and safety of sodium ferulate combined with methylcobalamin in the treatment of OIPN in CRC patients.

Methods

In this retrospective cohort study, 280 CRC patients diagnosed with OIPN following oxaliplatin-based chemotherapy at Qianxi People’s Hospital between January 2020 and December 2024 were enrolled. Based on treatment regimen, patients were assigned to an observation group (sodium ferulate combined with methylcobalamin, n = 152) or a control group (methylcobalamin alone, n = 128). All patients received basic nursing care. Treatment duration was 8 weeks for both groups. Outcomes compared between groups included National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) neurotoxicity grading, nerve conduction velocity (NCV), and quality of life (QoL) scores assessed before treatment, at 4 weeks, and at 8 weeks post-treatment. Clinical efficacy was evaluated after 8 weeks, and changes in hematological parameters and liver/kidney function indicators were monitored.

Results

Baseline characteristics were comparable between the two groups (p > 0.05). While no significant difference in neurotoxicity grading was observed at 4 weeks (p > 0.05), the observation group demonstrated significantly better NCI-CTCAE grades than the control group at 8 weeks (p < 0.05). NCV assessments revealed that motor and sensory NCVs of the median and common peroneal nerves in the observation group were significantly improved compared to both baseline levels and the control group at 4 and 8 weeks (p < 0.05). After 8 weeks, the overall clinical efficacy rate was significantly higher in the observation group (89.47%) than in the control group (67.97%) (p < 0.05). QoL scores across all functional domains (physical, role, cognitive, emotional, and social) were significantly better in the observation group compared to the control group at 8 weeks (p < 0.05). Hematological and liver/kidney function parameters remained within normal ranges and showed no significant intergroup differences post-treatment (p > 0.05).

Conclusion

The combination of sodium ferulate and methylcobalamin is superior to methylcobalamin monotherapy in alleviating the severity of neurotoxicity, improving nerve conduction function, enhancing clinical efficacy, and promoting quality of life in CRC patients with OIPN, with a comparable safety profile. It represents a promising clinical treatment option for OIPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin B 12Peripheral Nervous System DiseasesOxaliplatinColorectal NeoplasmsCoumaric AcidsAntineoplastic AgentsHumansRetrospective StudiesFemaleMaleMiddle AgedAgedQuality of LifeAdult

Stichwörter der Autor:innen

colorectal cancermethylcobalaminoxaliplatinperipheral neuropathysodium ferulate

Substanzen

Vitamin B 12mecobalaminOxaliplatinCoumaric Acidsferulic acidAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, Qianxi People's Hospital, 551599 Bijie, Guizhou, China.
  • Department of Pain, Qianxi People's Hospital, 551599 Bijie, Guizhou, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, 550001 Guiyang, Guizhou, China.

Förderung

  • Guizhou Provincial Science and Technology Foundation Project

Zitieren

APA

Min, B., Wan, L., He, H., Chen, J., Jian, Z., & Chen, R. (2026). A Retrospective Comparative Study of Sodium Ferulate Combined With Methylcobalamin for Oxaliplatin-Induced Peripheral Neuropathy in Patients With Colorectal Cancer. British Journal of Hospital Medicine, 87(6). https://doi.org/10.31083/bjhm55138

Vancouver

Min B, Wan L, He H, Chen J, Jian Z, Chen R. A Retrospective Comparative Study of Sodium Ferulate Combined With Methylcobalamin for Oxaliplatin-Induced Peripheral Neuropathy in Patients With Colorectal Cancer. British Journal of Hospital Medicine. 2026;87(6). doi:10.31083/bjhm55138

BibTeX
@article{Min2026,
  author = {Min, Baojun and Wan, Li and He, Hongyong and Chen, Jie and Jian, Zhonglu and Chen, Rong},
  title = {A Retrospective Comparative Study of Sodium Ferulate Combined With Methylcobalamin for Oxaliplatin-Induced Peripheral Neuropathy in Patients With Colorectal Cancer},
  journal = {British Journal of Hospital Medicine},
  year = {2026},
  volume = {87},
  number = {6},
  doi = {10.31083/bjhm55138}
}
Kostenlos starten →